Patent AnalyticsExaminers
Rankings

Company or institution

ANGIOCRINE BIOSCIENCE, INC.

14 applicationsfiled 2016 to 2025

Allowance rate
n/a
Needs 10 decided cases; has 8
Rejections before allowance
n/a
Needs 5 decided cases; has 3
Months to first action
28.0 mo
+9.4 vs the USPTO
Needed an RCE
63%
+35 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations8 apps
C12N Microorganisms or enzymes4 apps
A61L 1 apps
C07K Peptides1 apps

Art units

16314 apps
16323 apps
16333 apps
16751 apps
OPAP1 apps
16381 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19381059METHODS AND COMPOSITIONS FOR STEM CELL TRANSPLANTATION2025-11-06Pending00n/a
19316740ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR2025-09-02Pending00n/a
19149372Use Of Umbilical Vein Endothelial Cells For The Treatment Of Lung Injury2025-07-18Pending00n/a
15894902Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15203371Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15849681Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15690104Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15786420Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15246478Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15328731Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 14 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in